Petersson A S, Steen H, Kalume D E, Caidahl K, Roepstorff P
Department of Clinical Physiology, Sahlgrenska University Hospital, Göteborg, Sweden.
J Mass Spectrom. 2001 Jun;36(6):616-25. doi: 10.1002/jms.161.
In vivo nitration of tyrosine residues is a post-translational modification mediated by peroxynitrite that may be involved in a number of diseases. The aim of this study was to evaluate possibilities for site-specific detection of tyrosine nitration by mass spectrometry. Angiotensin II and bovine serum albumin (BSA) nitrated with tetranitromethane (TNM) were used as model compounds. Three strategies were investigated: (i) analysis of single peptides and protein digests by matrix-assisted laser desorption/ionization (MALDI) peptide mass mapping, (ii) peptide mass mapping by electrospray ionization (ESI) mass spectrometry and (iii) screening for nitration by selective detection of the immonium ion of nitrotyrosine by precursor ion scanning with subsequent sequencing of the modified peptides. The MALDI time-of-flight mass spectrum of nitrated angiotensin II showed an unexpected prompt fragmentation involving the nitro group, in contrast to ESI-MS, where no fragmentation of nitrated angiotensin II was observed. The ESI mass spectra showed that mono- and dinitrated angiotensin II were obtained after treatment with TNM. ESI-MS/MS revealed that the mononitrated angiotensin II was nitrated on the side-chain of tyrosine. The dinitrated angiotensin II contained two nitro groups on the tyrosine residue. Nitration of BSA was confirmed by Western blotting with an antibody against nitrotyrosine and the sites for nitration were investigated by peptide mass mapping after in-gel digestion. Direct mass mapping by ESI revealed that two peptides were nitrated. Precursor ion scanning for the immonium ion for nitrotyrosine revealed two additional partially nitrated peptides. Based on the studies with the two model compounds, we suggest that the investigation of in vivo nitration of tyrosine and identification of nitrated peptides might be performed by precursor ion scanning for the specific immonium ion at m/z 181.06 combined with ESI-MS/MS for identification of the specific nitration sites.
酪氨酸残基的体内硝化是一种由过氧亚硝酸盐介导的翻译后修饰,可能与多种疾病有关。本研究的目的是评估通过质谱进行酪氨酸硝化位点特异性检测的可能性。用四硝基甲烷(TNM)硝化的血管紧张素II和牛血清白蛋白(BSA)用作模型化合物。研究了三种策略:(i)通过基质辅助激光解吸/电离(MALDI)肽质量图谱分析单个肽段和蛋白质消化产物;(ii)通过电喷雾电离(ESI)质谱进行肽质量图谱分析;(iii)通过前体离子扫描选择性检测硝基酪氨酸的铵离子,随后对修饰肽段进行测序以筛选硝化作用。与ESI-MS不同,硝化血管紧张素II的MALDI飞行时间质谱显示涉及硝基的意外快速碎片化,在ESI-MS中未观察到硝化血管紧张素II的碎片化。ESI质谱表明,用TNM处理后获得了单硝化和二硝化的血管紧张素II。ESI-MS/MS显示,单硝化的血管紧张素II在酪氨酸侧链上被硝化。二硝化的血管紧张素II在酪氨酸残基上含有两个硝基。用抗硝基酪氨酸抗体进行蛋白质印迹证实了BSA的硝化作用,并通过凝胶内消化后的肽质量图谱研究了硝化位点。ESI直接质量图谱显示有两个肽段被硝化。对硝基酪氨酸的铵离子进行前体离子扫描发现了另外两个部分硝化的肽段。基于对这两种模型化合物的研究,我们建议通过对m/z 181.06处特定铵离子的前体离子扫描结合ESI-MS/MS来鉴定特定硝化位点,从而对酪氨酸的体内硝化进行研究并鉴定硝化肽段。